Kidney dysfunction, including chronic kidney disease and acute kidney injury, is a globally prevalent health problem. However, treatment regimens are still lacking, especially for conditions involving kidney fibrosis. Stem cells hold great promise in the treatment of chronic kidney disease and acute kidney injury, but success has been hampered by insufficient incorporation of the stem cells in the injured kidney. Thus, new approaches for the restoration of kidney function after acute or chronic injury have been explored. Recently, kidney organoids have emerged as a useful tool in the treatment of kidney diseases. In this review, we discuss the mechanisms and approaches of cell therapy in acute kidney injury and chronic kidney disease, including diabetic kidney disease and lupus nephritis. We also summarize the potential applications of kidney organoids in the treatment of kidney diseases.
Impact statement
Stem cells hold great promise in regenerative medicine. Pluripotent stem cells have been differentiated into kidney organoids to understand human kidney development and to dissect renal disease mechanisms. Meanwhile, recent studies have explored the treatment of kidney diseases using a variety of cells, including mesenchymal stem cells and renal derivatives. This mini-review discusses the diverse mechanisms underlying current renal disease treatment via stem cell therapy. We postulate that clinical applications of stem cell therapy for kidney diseases can be readily achieved in the near future.
ZhangLWangFWangLWangWLiuBLiuJChenMHeQLiaoYYuXChenNZhangJEHuZLiuFHongDMaLLiuHZhouXChenJPanLChenWWangWLiXWangH.Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet2012;
379:815–22
2.
HosteEAJKellumJASelbyNMZarbockAPalevskyPMBagshawSMGoldsteinSLCerdáJChawlaLS.Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol2018;
14:607–25
3.
ChawlaLSEggersPWStarRAKimmelPL.Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med2014;
371:58–66
4.
MorizaneRBonventreJV.Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells. Nat Protoc2017;
12:195–207
5.
ZhouXJKlionskyDJZhangH.Podocytes and autophagy: a potential therapeutic target in lupus nephritis. Autophagy2019;
15:908–12
LazzeriEAngelottiMLPeiredAConteCMarschnerJAMaggiLMazzinghiBLombardiDMelicaMENardiSRonconiESistiAAntonelliGBecherucciFDe ChiaraLGuevaraRRBurgerASchaeferBAnnunziatoFAndersHJLasagniLRomagnaniP.Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury. Nat Commun2018;
9:1344
8.
WongCYTanELCheongSK.In vitro differentiation of mesenchymal stem cells into mesangial cells when co-cultured with injured mesangial cells. Cell Biol Int2014;
38:497–501
9.
RangelEBGomesSAKanashiro-TakeuchiRSaltzmanRGWeiCRuizPReiserJHareJM.Kidney-derived c-kit+ progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuria. Sci Rep2018;
8:14723
10.
LangeCTögelFIttrichHClaytonFNolte-ErnstingCZanderARWestenfelderC.Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int2005;
68:1613–7
EzquerFGiraud-BilloudMCarpioDCabezasFCongetPEzquerM.Proregenerative microenvironment triggered by donor mesenchymal stem cells preserves renal function and structure in mice with severe diabetes mellitus. Biomed Res Int2015;
2015:164703
13.
LvSChengJSunALiJWangWGuanGLiuGSuM.Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress. Diabetes Res Clin Pract2014;
104:143–54
14.
ParkJHHwangIHwangSHHanHHaH.Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res Clin Pract2012;
98:465–73
15.
HanYSKimSMLeeJHJungSKNohHLeeSH.Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrPC-dependent enhancement of the mitochondrial function. J Pineal Res2019;
66:e12535
16.
LiHZhangYLiuSLiFWangBWangJCaoLXiaTYaoQChenHZhangYZhuXLiYLiGWangJLiXNiS.Melatonin enhances proliferation and modulates differentiation of neural stem cells via autophagy in hyperglycemia. Stem Cells2019;
37:504–15
17.
YoonYMHanYSYunCWLeeJHKimRLeeSH.Pioglitazone protects mesenchymal stem cells against P-Cresol-Induced mitochondrial dysfunction via up-regulation of PINK-1. Int J Mol Sci2018;
19:2898
18.
QiuGZhengGGeMWangJHuangRShuQXuJ.Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther2018;
9:320
19.
BaglioSRPegtelDMBaldiniN.Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol2012;
3:359
20.
ZouXGuDXingXChengZGongDZhangGZhuY.Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats. Am J Transl Res2016;
8:4289–99
21.
JuGQChengJZhongLWuSZouXYZhangGYGuDMiaoSZhuYJSunJDuT.Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction. PLoS One2015;
10:e0121534
22.
LiuZJShirakawaTLiYSomaAOkaMDottoGPFairmanRMVelazquezOCHerlynM.Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol2003;
23:14–25
23.
EirinAZhuXYJonnadaSLermanAvan WijnenAJLermanLO.Mesenchymal stem Cell-derived extracellular vesicles improve the renal microvasculature in metabolic renovascular disease in swine. Cell Transplant2018;
27:1080–95
24.
EbrahimNAhmedIAHussienNIDessoukyAAFaridASElshazlyAMMostafaOGazzarWBESorourSMSeleemYHusseinAMSabryD.Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells2018;
7:226
25.
RanghinoABrunoSBussolatiBMoggioADimuccioVTapparoMBianconeLGonteroPFreaBCamussiG.The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury. Stem Cell Res Ther2017;
8:24
ZhangAWangHWangBYuanYKleinJDWangXH.Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease. FASEB J2019;
33:13590–601
30.
ZhuFChong Lee ShinOLSPeiGHuZYangJZhuHWangMMouJ, , SunJWangYYangQZhaoZXuHGaoHYaoWLuoXLiaoWXuGZengRYaoY.Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation. Oncotarget2017;
8:70707–26
31.
KendallRTFeghali-BostwickCA.Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol2014;
5:123
32.
KawakamiTGomezIGRenSHudkinsKRoachAAlpersCEShanklandSJD’AgatiVDDuffieldJS.Deficient autophagy results in mitochondrial dysfunction and FSGS. J Am Soc Nephrol2015;
26:1040–52
33.
WangBJiaHZhangBWangJJiCZhuXYanYYinLYuJQianHXuW.Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Res Ther2017;
8:75
34.
MizushimaNYoshimoriTOhsumiY.The role of atg proteins in autophagosome formation. Annu Rev Cell Dev Biol2011;
27:107–32
35.
JiaHLiuWZhangBWangJWuPTandraNLiangZJiCYinLHuXYanYMaoFZhangXYuJXuWQianH.HucMSC exosomes-delivered 14-3-3ζ enhanced autophagy via modulation of ATG16L in preventing cisplatin-induced acute kidney injury. Am J Transl Res2018;
10:101–13
36.
JinJShiYGongJZhaoLLiYHeQHuangH.Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther2019;
10:95
37.
AndrianovaNVZorovaLDBabenkoVAPevznerIBPopkovVASilachevDNPlotnikovEYZorovDB.Rapamycin is not protective against ischemic and cisplatin-induced kidney injury. Biochemistry2019;
84:1502–12
38.
YinFYanJZhaoYGuoKJZhangZLLiAPMengCYGuoL.Bone marrow mesenchymal stem cells repair Cr (VI)- injured kidney by regulating mitochondria-mediated apoptosis and mitophagy mediated via the MAPK signaling pathway. Ecotoxicol Environ Saf2019;
176:234–41
39.
RashedLAElattarSEltablawyNAshourHMahmoudLMEl-EsawyY.Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy. Biochem Cell Biol2018;
96:564–71
40.
XiangJJiangTZhangWXieWTangXZhangJ.Human umbilical cord-derived mesenchymal stem cells enhanced HK-2 cell autophagy through MicroRNA-145 by inhibiting the PI3K/AKT/mTOR signaling pathway. Exp Cell Res2019;
378:198–205
41.
TangQWuHLeiJYiCXuWLanWYangFLiuC.HIF1α deletion facilitates adipose stem cells to repair renal fibrosis in diabetic mice. In Vitro Cell Dev Biol Anim2018;
54:272–86
42.
CzabotarPELesseneGStrasserAAdamsJM.Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol2014;
15:49–63
43.
CzabotarPEWestphalDDewsonGMaSHockingsCFairlieWDLeeEFYaoSRobinAYSmithBJHuangDCKluckRMAdamsJMColmanPM.Bax crystal structures reveal how BH3 domains activate bax and nucleate its oligomerization to induce apoptosis. Cell2013;
152:519–31
44.
LeeYJLeeC.Porcine deltacoronavirus induces caspase-dependent apoptosis through activation of the cytochrome c-mediated intrinsic mitochondrial pathway. Virus Res2018;
253:112–23
45.
AraiSKitadaKYamazakiTTakaiRZhangXTsugawaYSugisawaRMatsumotoAMoriMYoshiharaYDoiKMaeharaNKusunokiSTakahataANoiriESuzukiYYahagiNNishiyamaAGunaratnamLTakanoTMiyazakiT.Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med2016;
22:183–93
46.
FuhrmannDCBrüneB.Mitochondrial composition and function under the control of hypoxia. Redox Biol2017;
12:208–15
47.
InoueTMaekawaHInagiR.Organelle crosstalk in the kidney. Kidney Int2019;
95:1318–25
48.
LiBLeungJCKChanLYYYiuWHLiYLokSWYLiuWHChanKWTseHFLaiKNTangS.Amelioration of endoplasmic reticulum stress by mesenchymal stem cells via hepatocyte growth factor/c-Met signaling in obesity-associated kidney injury. Stem Cells Transl Med2019;
8:898–910
49.
InagiRIshimotoYNangakuM.Proteostasis in endoplasmic reticulum – new mechanisms in kidney disease. Nat Rev Nephrol2014;
10:369–78
50.
SureshbabuARyterSWChoiME.Oxidative stress and autophagy: crucial modulators of kidney injury. Redox Biol2015;
4:208–14
51.
TraczMJJuncosJPCroattAJAckermanAWGrandeJPKnutsonKLKaneGCTerzicAGriffinMDNathKA.Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int2007;
72:1073–80
52.
GaoGWangWTadagavadiRKBrileyNELoveMIMillerBAReevesWB. ]
TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. J Clin Invest2014;
124:4989–5001
53.
ChenBLSheuMLTsaiKSLanKCGuanSSWuCTChenLPHungKYHuangJWChiangCKLiuSH.CCAAT-Enhancer-Binding protein homologous protein deficiency attenuates oxidative stress and renal Ischemia-Reperfusion injury. Antioxid Redox Signal2015;
23:1233–45
54.
SongIHJungKJLeeTJKimJYSungEGBaeYCParkYH.Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB. Nephrology2018;
23:483–92
55.
LiuBDingFXLiuYXiongGLinTHeDWZhangYYZhangDYWeiGH.Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction. Nephrology2018;
3:728–36
56.
XieLBChenXChenBWangXDJiangRLuYP.Protective effect of bone marrow mesenchymal stem cells modified with klotho on renal ischemia-reperfusion injury. Ren Fail2019;
41:175–82
57.
ZhouDTanRJLinLZhouLLiuY.Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury. Kidney Int2013;
84:509–20
58.
ZhuXYUrbieta-CaceresVKrierJDTextorSCLermanALermanLO.Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells2013;
31:117–25
59.
ShenWCChouYHHuangHPSheenJFHungSCChenHF.Induced pluripotent stem cell-derived endothelial progenitor cells attenuate ischemic acute kidney injury and cardiac dysfunction. Stem Cell Res Ther2018;
9:344
60.
ZhangJBWangXQLuGLHuangHSXuSY.Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model. Clin Exp Pharmacol Physiol2017;
44:1232–40
61.
ZhangRYinLZhangBShiHSunYJiCChenJWuPZhangLXuWQianH.Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death Dis2018;
9:965
62.
JiaoXCaiJYuXDingX.Paracrine activation of the Wnt/β-Catenin pathway by bone marrow stem cell attenuates cisplatin-induced kidney injury. Cell Physiol Biochem2017;
44:1980–94
63.
TianSFJiangZZLiuYMNiuXHuBGuoSCWangNSWangY.Human urine-derived stem cells contribute to the repair of ischemic acute kidney injury in rats. Mol Med Rep2017;
6:5541–8
EdelingMRagiGHuangSPavenstädtHSusztakK.Developmental signalling pathways in renal fibrosis: the roles of notch, Wnt and hedgehog. Nat Rev Nephrol2016;
12:426–39
66.
ChenGYNuñezG.Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol2010;
10:826–37
67.
VescovoGCastellaniCFedrigoMVirzìGMVescovoGMTavanoRPozzobonMAngeliniA.Stem cells transplantation positively modulates the heart-kidney cross talk in cardiorenal syndrome type II. Int J Cardiol2019;
275:136–44
68.
LiuJLuXLouYCaiYCuiWWangJNiePChenLLiBLuoP.Xenogeneic transplantation of human Placenta-Derived mesenchymal stem cells alleviates renal injury and reduces inflammation in a mouse model of lupus nephritis. Biomed Res Int2019;
2019:9370919
69.
DayYJHuangLYeHLiLLindenJOkusaMD.Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol2006;
176:3108–14
70.
WeiXZhangJGuQHuangMZhangWGuoJZhouX.Reciprocal expression of IL-35 and IL-10 defines two distinct effector Treg subsets that are required for maintenance of immune tolerance. Cell Rep2017;
21:1853–69
71.
ShiYWangYLiQLiuKHouJShaoCWangY.Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol2018;
14:493–507
72.
VasandanABJahnaviSShashankCPrasadPKumarAPrasannaSJ.Human mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism. Sci Rep2016;
6:38308
73.
WangGCaoKLiuKXueYRobertsAILiFHanYRabsonABWangYShiY.Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ2018;
25:1209–23
74.
MittalMTiruppathiCNepalSZhaoYYGrzychDSoniDProckopDJMalikAB.TNFα-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury. Proc Natl Acad Sci U S A2016;
113:E8151–8
75.
XingLSongEYuCYJiaXBMaJSuiMSWangMAGaoX.Bone Marrow-derived mesenchymal stem cells attenuate tubulointerstitial injury through multiple mechanisms in UUO model. J Cell Biochem2018;
120:9737–46
76.
RotaCMorigiMCerulloDIntronaMColpaniOCornaDCapelliCRabelinkTJLeuningDGRottoliDBenigniAZojaCRemuzziG.Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease. Stem Cell Res Ther2018;
9:220
77.
LiYLiuJLiaoGZhangJChenYLiLLiLLiuFChenBGuoGWangCYangLChengJLuY.Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment. Int J Mol Med2018;
41:2629–39
78.
HamzaAHAl-BishriWMDamiatiLAAhmedHH.Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy. Ren Fail2017;
39:67–76
79.
HeXZhangYZhuAZengKZhangXGongLPengYLaiKQuS.Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus. Immunol Res2016;
64:1157–67
80.
KilpinenLImpolaUSankkilaLRitamoIAatonenMKilpinenSTuimalaJValmuLLevijokiJFinckenbergPSiljanderPKankuriEMervaalaELaitinenS.Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracell Vesicles2013;
2:21927
BoreströmCJonebringAGuoJPalmgrenHCederbladLForslöwASvenssonASöderbergMReznichenkoANyströmJPatrakkaJHicksRMarescaMValastroBCollénA.A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery. Kidney Int2018;
94:1099–110
86.
KrauseMRak-RaszewskaANaillatFSaarelaUSchmidtCRonkainenVPBartGYlä-HerttualaSVainioSJ.Exosomes as secondary inductive signals involved in kidney organogenesis. J Extracell Vesicles2018;
7:1422675
87.
HomanKAGuptaNKrollKTKoleskyDBSkylar-ScottMMiyoshiTMauDValeriusMTFerranteTBonventreJVLewisJAMorizaneR.Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat Methods2019;
16:255–62
88.
LowJHLiPChewEGYZhouBSuzukiKZhangTLianMMLiuMAizawaERodriguez EstebanCYongKSMChenQCampistolJMFangMKhorCCFooJNIzpisua BelmonteJCXiaY.Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network. Cell Stem Cell2019;
25:373–87
89.
van den BergCWRitsmaLAvramutMCWiersmaLEvan den BergBMLeuningDGLieversEKoningMVanslambrouckJMKosterAJHowdenSETakasatoMLittleMHRabelinkTJ.Renal subcapsular transplantation of PSC-derived kidney organoids induces neo-vasculogenesis and significant glomerular and tubular maturation in vivo. Stem Cell Rep2018;
10:751–65
90.
GarretaEPradoPTarantinoCOriaRFanloLMartíEZalvideaDTrepatXRoca-CusachsPGavaldà-NavarroACozzutoLCampistolJMIzpisúa BelmonteJCHurtado Del PozoCMontserratN.Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells. Nat Mater2019;
18:397–405
91.
TakasatoMErPXChiuHSMaierBBaillieGJFergusonCPartonRGWolvetangEJRoostMSChuva de Sousa LopesSMLittleMH.Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature2015;
526:564–8
92.
CruzNMSongXCzernieckiSMGulievaREChurchillAJKimYKWinstonKTranLMDiazMAFuHFinnLSPeiYHimmelfarbJFreedmanBS.Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nat Mater2017;
16:1112–9
93.
TanigawaSIslamMSharminSNaganumaHYoshimuraYHaqueFEraTNakazatoHNakanishiKSakumaTYamamotoTKuriharaHTaguchiANishinakamuraR.Organoids from nephrotic Disease-Derived iPSCs identify impaired NEPHRIN localization and slit diaphragm formation in kidney podocytes. Stem Cell Rep2018;
11:727–40
94.
HaleLJHowdenSEPhipsonBLonsdaleAErPXGhobrialIHosawiSWilsonSLawlorKTKhanSOshlackAQuinlanCLennonRLittleMH.3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening. Nat Commun2018;
9:5167
95.
HarderJLMenonROttoEAZhouJEddySWysNLO’ConnorCLuoJNairVCebrianCSpenceJRBitzerMTroyanskayaOGHodginJBWigginsRCFreedmanBSKretzlerM, European Renal cDNA Bank (ERCB); Nephrotic Syndrome Study Network (NEPTUNE).
Organoid single cell profiling identifies a transcriptional signature of glomerular disease. JCI Insight2019;
4:122697
96.
RahmanMSWruckWSpitzhornLSNguyenLBohndorfMMartinsSAsarFNcubeAErichsenLGraffmannNAdjayeJ.The FGF, TGFβ and WNT axis modulate self-renewal of human SIX2+ urine derived renal progenitor cells. Sci Rep2020;
10:739.
97.
RogersSALowellJAHammermanNAHammermanMR.Transplantation of developing metanephroi into adult rats. Kidney Int1998;
54:27–37
98.
MarshallDClancyMBottomleyMSymondsKBrenchleyPEBraveryCA.Transplantation of metanephroi to sites within the abdominal cavity. Transplant Proc2005;
37:194–7
99.
NamSASeoEKimJWKimHWKimHLKimKKimTMJuJHGomezIGUchimuraKHumphreysBDYangCWLeeJYKimJChoDWFreedmanBSKimYK.Graft immaturity and safety concerns in transplanted human kidney organoids. Exp Mol Med2019;
51:1–13
100.
HuangXChenWRenGZhaoLGuoJGongDZengCHuWLiuZ.Autologous hematopoietic stem cell transplantation for refractory lupus nephritis. Clin J Am Soc Nephrol2019;
14:719–27
101.
SidiqiMHAljamaMABuadiFKWarsameRMLacyMQDispenzieriADingliDGonsalvesWIKumarSKapoorPKourelisTHoganWJGertzMA.Stem cell transplantation for light chain amyloidosis: decreased early mortality over time. J Clin Oncol2018;
36:1323–9
102.
YuXJZhangXLiDYWangSXZhouFDZhaoMH.Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: a large retrospective case series study from a single institute in China. Nephrology2020;
25:202–11
103.
MakhloughAShekarchianSMoghadasaliREinollahiBDastgheibMJanbabaeeGHosseiniSEFalahNAbbasiFBaharvandHAghdamiN.Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: a safety study with 18 months of follow-up. Cytotherapy2018;
20:660–9
104.
LeeMSLeeFYChenYLSungPHChiangHJChenKHHuangTHChenYLChiangJYYinTCChangHWYipHK.Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial. Oncotarget2017;
8:17750–62
105.
ZouXGuDZhangGZhongLChengZLiuGZhuY.NK cell regulatory property is involved in the protective role of MSC-Derived extracellular vesicles in renal ischemic reperfusion injury. Hum Gene Ther2016;
27:926–35
106.
ZhongLLiaoGWangXLiLZhangJChenYLiuJLiuSWeiLZhangWLuY.Mesenchymal stem cells-microvesicle-miR-451a ameliorate early diabetic kidney injury by negative regulation of P15 and P19. Exp Biol Med2018;
243:1233–42
107.
NagaishiKMizueYChikenjiTOtaniMNakanoMKonariNFujimiyaM.Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep2016;
6:34842
108.
FengJLuCDaiQShengJXuM.SIRT3 facilitates amniotic fluid stem cells to repair diabetic nephropathy through protecting mitochondrial homeostasis by modulation of mitophagy. Cell Physiol Biochem2018;
46:1508–24
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
